Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Outfront Media
OUT
$5.75B
| $3.31M | ﹤0.01% |
231,275
-1,051
| -0.5% | -$15.7K |
|
|
BERY
977
DELISTED
Berry Global Group, Inc.
BERY
| $3.27M | ﹤0.01% |
73,729
-6,608
| -8% | -$303K |
|
978
GeoPark
GPRK
$609M
| $3.27M | ﹤0.01% |
443,254
-351,286
| -44% | -$3.25M |
|
|
ETFC
979
DELISTED
E*Trade Financial Corporation
ETFC
| $3.26M | ﹤0.01% |
65,130
-30,120
| -32% | -$1.57M |
|
|
EPIX
980
DELISTED
ESSA Pharma
EPIX
| $3.26M | ﹤0.01% |
475,688
+74,092
| +18% | +$503K |
|
981
Ecovyst
ECVT
$1.32B
| $3.25M | ﹤0.01% |
317,287
+267,457
| +537% | +$3.26M |
|
982
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $3.23M | ﹤0.01% |
+33,677
| New | +$3.24M |
|
983
Napco Security Technologies
NSSC
$1.3B
| $3.19M | ﹤0.01% |
271,942
+145,968
| +116% | +$1.76M |
|
|
HES
984
DELISTED
Hess
HES
| $3.19M | ﹤0.01% |
77,963
+13,507
| +21% | +$642K |
|
985
Principal Financial Group
PFG
$24.3B
| $3.13M | ﹤0.01% |
77,741
-13,957
| -15% | -$595K |
|
986
Boston Properties
BXP
$11.6B
| $3.08M | ﹤0.01% |
38,374
+2,087
| +6% | +$182K |
|
987
BP
BP
$112B
| $3.03M | ﹤0.01% |
173,668
-51,302
| -23% | -$1.11M |
|
988
Open Text
OTEX
$6.28B
| $3.02M | ﹤0.01% |
71,614
+21,319
| +42% | +$932K |
|
989
Genuine Parts
GPC
$17.9B
| $2.98M | ﹤0.01% |
31,269
+2,096
| +7% | +$195K |
|
990
Oneok
OKE
$56.7B
| $2.97M | ﹤0.01% |
114,438
-330,531
| -74% | -$9.2M |
|
|
VER
991
DELISTED
VEREIT, Inc.
VER
| $2.95M | ﹤0.01% |
90,633
+7,845
| +9% | +$258K |
|
992
Pembina Pipeline
PBA
$29.3B
| $2.93M | ﹤0.01% |
138,466
+7,917
| +6% | +$194K |
|
993
Eastman Chemical
EMN
$7.69B
| $2.92M | ﹤0.01% |
37,320
+1,841
| +5% | +$139K |
|
994
Ionis Pharmaceuticals
IONS
$8.93B
| $2.88M | ﹤0.01% |
60,679
-8,848
| -13% | -$491K |
|
995
Pentair
PNR
$10.6B
| $2.88M | ﹤0.01% |
62,911
-97,881
| -61% | -$4.26M |
|
996
BCE
BCE
$20.8B
| $2.87M | ﹤0.01% |
69,525
+2,166
| +3% | +$91.6K |
|
|
AZPN
997
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.84M | ﹤0.01% |
22,451
+149
| +0.7% | +$18.9K |
|
998
Telephone and Data Systems
TDS
$3.87B
| $2.83M | ﹤0.01% |
153,396
+523
| +0.3% | +$11K |
|
|
LHCG
999
DELISTED
LHC Group LLC
LHCG
| $2.8M | ﹤0.01% |
13,178
-2,288
| -15% | -$451K |
|
|
ORTX
1000
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.78M | ﹤0.01% |
67,675
-40,420
| -37% | -$2.09M |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.